CLDF-GHAPP Podcast Series: MASH
4 Part Series
Hosted by: Nadege Gunn, MD
With Special Guests: Elizabeth Goacher, PA, and Ann Moore, NP
Related Podcast

Part 1 - Incorporating the Newly Approved Therapy for MASH into Practice
2024

What Is the Clinical Profile of Resmetirom, Including Dosing Schedules?
2025

What Is Resmetirom and How Does It Work to Treat MASH?
2025

Part 4 - MASH- What We Don't Know, What We Want to Know
2024

How Is MASH Severity Staged? What Would an Ideal MASH NIT Algorithm Look Like?
2025

Part 3 - Strategies for Educating the APP Community on MASH
2024

What Are the Consequences of MASH Going Untreated?
2025

Key Takeaways - Major Advancements In The Management of MASH with Parvez, Mantry, MD
2024

A Phase 3, Randomized, Controlled Trial of Resmetirom in NASH with Liver Fibrosis
2025

What is MASH?
2025